Eric Tse

Mr. Eric Tse has served as an Executive Director of SBP Group since 2019, Chairman of CTTQ Pharma since 2020, and Chief Executive Officer of SBP Group as well as Chairman of Beijing Tide Pharmaceutical Co., Ltd. since 2022. He earned a Bachelor’s degree in Economics from the Wharton School of the University of Pennsylvania and a Master’s in Management from Schwarzman College, Tsinghua University, and is a Ph.D. candidate in Social and Administrative Pharmacy at China Pharmaceutical University. His recognitions include “Top 10 Outstanding Chinese American Youth” and “Advanced Individual for Outstanding Contribution to Jiangsu Manufacturing”. He holds multiple social‑sector positions: member of the Beijing Municipal Committee of the CPPCC, member of the 14th National Committee of the All‑China Youth Federation, Vice Chairman of the 13th Shaanxi Youth Federation, member of Hong Kong SAR’s 7th Election Committee, Vice President of the Hong Kong CPPCC Youth Association, and other roles across APEC China Business Council, World Economic Forum Global Shapers, Belt and Road General Chamber of Commerce and Jiangsu Overseas Chinese Entrepreneurs Association. Since assuming the CEO role, Mr. Tse has steered SBP Group around four core strategies: organizational integration, comprehensive innovation, internationalization and digitalization. He drives organizational efficiency, external partnerships and global innovation to build a world‑class Chinese innovative pharmaceutical enterprise.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.